These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19531054)
1. Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control. Raskin P; Lewin A; Reinhardt R; Lyness W; Diabetes Obes Metab; 2009 Oct; 11(10):947-52. PubMed ID: 19531054 [TBL] [Abstract][Full Text] [Related]
2. Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet. Raskin P; Lewin A; Reinhardt R; Lyness W; Diabetes Obes Metab; 2009 Sep; 11(9):865-73. PubMed ID: 19476470 [TBL] [Abstract][Full Text] [Related]
3. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia. Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078 [TBL] [Abstract][Full Text] [Related]
4. Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. Wang W; Bu R; Su Q; Liu J; Ning G Expert Opin Pharmacother; 2011 Dec; 12(18):2791-9. PubMed ID: 21780853 [TBL] [Abstract][Full Text] [Related]
5. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects. Hoelscher D; Chu PL; Lyness W Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804 [TBL] [Abstract][Full Text] [Related]
6. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. Lund SS; Tarnow L; Frandsen M; Nielsen BB; Hansen BV; Pedersen O; Parving HH; Vaag AA BMJ; 2009 Nov; 339():b4324. PubMed ID: 19900993 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone. Raskin P; McGill J; Saad MF; Cappleman JM; Kaye W; Khutoryansky N; Hale PM; Diabet Med; 2004 Apr; 21(4):329-35. PubMed ID: 15049934 [TBL] [Abstract][Full Text] [Related]
8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
9. Effect of repaglinide, administered two or three times daily for 3 months, on glycaemic control in Japanese patients with type 2 diabetes mellitus. Kamiyama H; Aoki K; Nakajima S; Shinoda K; Kamiko K; Taguri M; Terauchi Y J Int Med Res; 2014 Oct; 42(5):1150-60. PubMed ID: 25015763 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial. Ji L; Li L; Kuang J; Yang T; Kim DJ; Kadir AA; Huang CN; Lee D Diabetes Obes Metab; 2017 May; 19(5):754-758. PubMed ID: 28075066 [TBL] [Abstract][Full Text] [Related]
11. Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial. Gerstein HC; Garon J; Joyce C; Rolfe A; Walter CM Diabet Med; 2004 Nov; 21(11):1200-3. PubMed ID: 15498086 [TBL] [Abstract][Full Text] [Related]
12. Repaglinide in combination therapy with metformin in Type 2 diabetes. Moses R Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S136-9. PubMed ID: 10522839 [TBL] [Abstract][Full Text] [Related]
13. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. Derosa G; Salvadeo SA; D'Angelo A; Ferrari I; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF Curr Med Res Opin; 2009 Mar; 25(3):607-15. PubMed ID: 19232035 [TBL] [Abstract][Full Text] [Related]
14. Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes. Moses RG; Gomis R; Frandsen KB; Schlienger JL; Dedov I Diabetes Care; 2001 Jan; 24(1):11-5. PubMed ID: 11194214 [TBL] [Abstract][Full Text] [Related]
15. The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus. Reasner C; Olansky L; Seck TL; Williams-Herman DE; Chen M; Terranella L; Johnson-Levonas AO; Kaufman KD; Goldstein BJ Diabetes Obes Metab; 2011 Jul; 13(7):644-52. PubMed ID: 21410627 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a fixed-dose repaglinide/metformin combination tablet and equivalent doses of repaglinide and metformin tablets . Cho HY; Ngo L; Kim SK; Choi Y; Lee YB Int J Clin Pharmacol Ther; 2018 Jun; 56(6):292-300. PubMed ID: 29648532 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of repaglinide monotherapy and in combination with metformin in Indonesian type 2 diabetes mellitus patients. Soegondo S; Subekti I; Luthariana L Acta Med Indones; 2004; 36(3):142-7. PubMed ID: 15557683 [TBL] [Abstract][Full Text] [Related]
19. Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents. Furlong NJ; Hulme SA; O'Brien SV; Hardy KJ Diabet Med; 2003 Nov; 20(11):935-41. PubMed ID: 14632720 [TBL] [Abstract][Full Text] [Related]
20. Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China. Ma J; Liu LY; Wu PH; Liao Y; Tao T; Liu W J Diabetes Res; 2014; 2014():294017. PubMed ID: 24772445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]